Psychology Today9h
The Best Way to Treat Alcohol Use Disorder (AUD)
The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...
New Scientist15h
How GLP-1 drugs like Ozempic and Wegovy affect risk of 175 conditions
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
Amarillo Globe-News23h
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patients
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
The Financial Express1d
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Novo's Ozempic, Wegovy face US Medicare price negotiations
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...
US targets Novo Nordisk's Ozempic and Wegovy for Medicare price talks
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
pulmonologyadvisor5d
Ensifentrine Is a Promising Ancillary COPD Treatment Option
Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...